Cargando…
Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites
BACKGROUND: So-called "immunoprivileged sites" are tissues or organs where slow allograft rejection correlates with low levels of expression of MHC class I molecules. Whilst classical class I molecules are recognised by cytotoxic T lymphocytes (CTL), some MHC class I molecules are called &...
Autores principales: | Lau, Pierre, Amadou, Claire, Brun, Hélène, Rouillon, Virginie, McLaren, Fiona, Le Rolle, Anne-France, Graham, Margaret, Butcher, Geoffrey W, Joly, Etienne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC183868/ https://www.ncbi.nlm.nih.gov/pubmed/12837137 http://dx.doi.org/10.1186/1471-2172-4-7 |
Ejemplares similares
-
Correction: Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites
por: Lau, Pierre, et al.
Publicado: (2004) -
The orthology of HLA-E and H2-Qa1 is hidden by their concerted evolution with other MHC class I molecules
por: Joly, Etienne, et al.
Publicado: (2006) -
COVID-19, immunoprivilege and structural inequalities
por: Liz, Jordan
Publicado: (2021) -
Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach
por: Stevens, James, et al.
Publicado: (2001) -
Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
por: Berglund, Alix K., et al.
Publicado: (2017)